Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Use of Antiemetic Agents in Acute Gastroenteritis 3. 2008 Exclusive Survey—Earnings: Good news for primary care income 4. A randomised phase III study on capecitabine, oxaliplatin and bevacizumab with or without cetuximab in first-line advanced colorectal cancer, the CAIRO2 study of the Dutch Colorectal Cancer Group (DCCG). An interim analysis of toxicity 5. Medicare pay-for-reporting effort draws fire from frustrated doctors
Your Article Summary
See Latest ArticlesGene expression profiling of primary and metastatic colon cancers identifies a reduced proliferative rate in metastatic tumors
Clinical and Experimental Metastasis, 11/05/09
Ganepola GAP et al. – These findings may have implications for interpreting differences in response rates between primary and metastatic lesions and suggest that measurement of expression–based biomarkers in metastatic tissue will be most informative for understanding the basis of response of metastatic tumors to therapeutic intervention.
Today in Colorectal Cancer/Polyps...keeping you current
Receive free subspecialty "5-minute updates" via email
A randomized trial on folic acid supplementation and risk of recurrent colorectal adenoma
American Journal of Clinical Nutrition, 10/29/09
Localized resection for colon cancer
Surgical Oncology, 11/04/09
Treatment of Fistulizing Inflammatory Bowel Disease
Gastroenterology Clinics of North America, 11/13/09
Sponsor
Article Search
Sponsor